Teleflex Incorporated
NYSE:TFXMedical - Instruments & Supplies
+$1.04 today
- Market cap
- $6.58B
- Beta
- 0.82
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$22.79
- Dividend yield
- 1.08%
Volume 1.16M
Average 0.80M
TFX Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Teleflex IncorporatedNYSE: TFX
Selling, General & Admin · Q2 FY2026 · quarter ended Jun 2026
Selling, general & admin dips below year-ago levels
Q2 FY2026 selling, general & admin of $213.52M fell 0.7% year over year, behind the +0.4% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 5.5% from the prior quarter. Over 3 fiscal years it compounded at -5.9% a year.
Context
- Selling, general & admin amounted to 36.1% of revenue in FY2025, up 3.5 pp from a year earlier.
- Selling, general & admin increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether selling, general & admin reaches the consensus estimate from 9 analysts of $731.88M (+1.6%) for the fiscal year ending Dec 2026, a step up from the -27.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $213.52M-5.5% QoQ
- Last fiscal yearDec 2025
- $720.17M-27.6% YoY
- LTMJun 2026
- $943.66M+0.4% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 720.17M USD
- Year-over-year change
- -27.6%
- 4-year CAGR
- -4.3%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 720.17M | -27.6% |
| FY2024 | 2024-12-31 | 995.27M | +7.0% |
| FY2023 | 2023-12-31 | 929.87M | +7.7% |
| FY2022 | 2022-12-31 | 863.75M | +0.4% |
| FY2021 | 2021-12-31 | 860.09M | — |
Selling, General & Admin vs competitors
How TFX compares with its peers on the latest reported figures
- Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +0.4% is the 10th highest of 11, against a peer median of +11.9%.
- Selling, general & admin amounts to 36.3% of revenue for TFX, versus a peer median of 36.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.22B USD | +1.8% | +14.8% | 41.8% | |
| LTM Jun 2026 | $943.66M USD | +0.4% | -5.9% | 36.3% | |
| LTM Sep 2026 | $881.19M USD | +33.2% | +6.5% | 50.3% | |
| LTM Sep 2026 | $481.78M USD | +9.7% | +9.9% | 29.9% | |
| LTM Jun 2026 | $351.33M USD | +8.3% | +2.1% | 34.8% | |
| LTM Sep 2026 | $313.76M USD | +50.7% | +34.4% | 34.9% | |
| LTM Sep 2026 | $201.04M USD | +64.9% | +30.5% | 44.6% | |
| LTM Jun 2026 | $159.72M USD | +24.9% | +23.6% | 36.3% | |
| LTM Jun 2026 | $132.67M USD | +14.1% | +48.1% | — | |
| LTM Jun 2026 | €126.68M EUR | +3.9% | +3.2% | 10.4% | |
| LTM Sep 2026 | $68.9M USD | -6.0% | -10.5% | 273.7% | |
| Peer median (excluding TFX) | — | +11.9% | +12.4% | 36.3% | |
Competitors are the stored peer set for TFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.81B | 2.79B | 2.97B | 3.05B | 1.99B |
| Cost of Revenue | 1.26B | 1.26B | 1.33B | 1.34B | 871.96M |
| Gross Profit | 1.55B | 1.53B | 1.65B | 1.7B | 1.12B |
| Gross Margin | 55.2% | 54.9% | 55.4% | 55.9% | 56.2% |
| Research & Development | 130.84M | 153.82M | 154.35M | 161.67M | 144.78M |
| Selling, General & Admin | 860.09M | 863.75M | 929.87M | 995.27M | 720.17M |
| Operating Expenses | 921.51M | 1.03B | 1.14B | 1.55B | 864.95M |
| Depreciation & Amortization | 237.36M | 230.59M | 242.12M | 274.6M | 177.74M |
| EBITDA | 853.8M | 730.77M | 761.21M | 433.62M | 302.51M |
| EBITDA Margin | 30.4% | 26.2% | 25.6% | 14.2% | 15.2% |
| Operating Income | 628.1M | 499.73M | 506.31M | 151.01M | 255.8M |
| Operating Margin | 22.4% | 17.9% | 17.0% | 5.0% | 12.8% |
| Interest Income | 1.33M | 912K | 12.78M | 8.01M | 6.4M |
| Interest Expense | 56.97M | 54.26M | 85.08M | 83.54M | 100.22M |
| Other Income / Expenses | (68.63M) | (53.81M) | (72.3M) | (75.54M) | (231.25M) |
| Income Before Tax | 559.47M | 445.92M | 434.01M | 75.48M | 24.55M |
| Pre-Tax Margin | 19.9% | 16.0% | 14.6% | 2.5% | 1.2% |
| Income Tax Expense | 74.35M | 83M | 76.44M | 5.32M | (33.98M) |
| Net Income | 485.37M | 363.14M | 356.33M | 69.68M | (905.64M) |
| Net Margin | 17.3% | 13.0% | 12.0% | 2.3% | -45.4% |
| EPS (Basic) | 10.38 | 7.74 | 7.58 | 1.49 | (20.30) |
| EPS (Diluted) | 10.23 | 7.68 | 7.53 | 1.48 | (20.25) |
| Weighted Avg Shares | 46.77M | 46.9M | 46.98M | 46.84M | 44.62M |
| Weighted Avg Shares (Diluted) | 47.43M | 47.31M | 47.3M | 47.09M | 44.72M |
Teleflex Incorporated
NYSE:TFX
Intrinsic Alpha fair value
Locked
Current Price
$165.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.